HK1158200A1 - 稠合的哌嗪- -酮衍生物的製備方法 - Google Patents

稠合的哌嗪- -酮衍生物的製備方法

Info

Publication number
HK1158200A1
HK1158200A1 HK11112665.6A HK11112665A HK1158200A1 HK 1158200 A1 HK1158200 A1 HK 1158200A1 HK 11112665 A HK11112665 A HK 11112665A HK 1158200 A1 HK1158200 A1 HK 1158200A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
producing
annelated
piperazin
annelated piperazin
Prior art date
Application number
HK11112665.6A
Other languages
English (en)
Inventor
阿迪爾‧杜蘭
岡特‧林茨
Original Assignee
貝林格爾．英格海姆國際有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35923724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1158200(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 貝林格爾．英格海姆國際有限公司 filed Critical 貝林格爾．英格海姆國際有限公司
Publication of HK1158200A1 publication Critical patent/HK1158200A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
HK11112665.6A 2004-12-02 2011-11-23 稠合的哌嗪- -酮衍生物的製備方法 HK1158200A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004058337A DE102004058337A1 (de) 2004-12-02 2004-12-02 Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten

Publications (1)

Publication Number Publication Date
HK1158200A1 true HK1158200A1 (zh) 2012-07-13

Family

ID=35923724

Family Applications (3)

Application Number Title Priority Date Filing Date
HK08103652.5A HK1113489A1 (en) 2004-12-02 2008-04-02 Method for producing annelated piperazin-2-one derivatives and intermediates of said method
HK11112665.6A HK1158200A1 (zh) 2004-12-02 2011-11-23 稠合的哌嗪- -酮衍生物的製備方法
HK11112664.7A HK1158199A1 (en) 2004-12-02 2011-11-23 Method for producing annelated piperazin-2-one derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK08103652.5A HK1113489A1 (en) 2004-12-02 2008-04-02 Method for producing annelated piperazin-2-one derivatives and intermediates of said method

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11112664.7A HK1158199A1 (en) 2004-12-02 2011-11-23 Method for producing annelated piperazin-2-one derivatives

Country Status (35)

Country Link
US (9) US7238807B2 (zh)
EP (2) EP1819706B1 (zh)
JP (1) JP5164574B2 (zh)
KR (2) KR101362131B1 (zh)
CN (3) CN102070637B (zh)
AR (1) AR053100A1 (zh)
AU (1) AU2005311308B2 (zh)
BR (1) BRPI0518601A2 (zh)
CA (1) CA2588857C (zh)
CL (1) CL2013002895A1 (zh)
CY (1) CY1113625T1 (zh)
DE (1) DE102004058337A1 (zh)
DK (2) DK2436685T3 (zh)
EA (1) EA012624B1 (zh)
ES (2) ES2548680T3 (zh)
HK (3) HK1113489A1 (zh)
HR (1) HRP20120980T1 (zh)
HU (1) HUE027689T2 (zh)
IL (1) IL183568A (zh)
ME (1) ME01470B (zh)
MX (1) MX2007006549A (zh)
MY (1) MY147459A (zh)
NO (1) NO20072283L (zh)
NZ (1) NZ556182A (zh)
PE (2) PE20061061A1 (zh)
PL (2) PL2436685T3 (zh)
PT (1) PT1819706E (zh)
RS (1) RS52533B (zh)
SG (2) SG158848A1 (zh)
SI (1) SI1819706T1 (zh)
TW (1) TWI362391B (zh)
UA (1) UA89390C2 (zh)
UY (1) UY29233A1 (zh)
WO (1) WO2006058876A1 (zh)
ZA (1) ZA200703368B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) * 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
WO2007095188A2 (en) 2006-02-14 2007-08-23 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
JP4958461B2 (ja) * 2006-03-30 2012-06-20 富士フイルム株式会社 近赤外吸収色素含有硬化性組成物
RU2009132605A (ru) 2007-02-01 2011-03-10 Астразенека Аб (Se) Производные 5,6,7,8-тетрагидроптеридина в качестве ингибиторов hsp90
WO2009019205A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
EP2100894A1 (en) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
CN102020643A (zh) 2009-09-22 2011-04-20 上海恒瑞医药有限公司 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
SG179207A1 (en) 2009-09-25 2012-04-27 Vertex Pharma Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
BR112012006652A2 (pt) 2009-09-25 2015-09-08 Vertex Pharma métodos para preparar os derivados de pirimidina úteis como inibidores de proteína cinase
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
CA2827770A1 (en) 2011-02-25 2012-11-01 Takeda Pharmaceutical Company Limited N-substituted oxazinopteridines and oxazinopteridinones
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
AR099052A1 (es) 2014-01-09 2016-06-29 Takeda Pharmaceuticals Co Derivados de azaindol
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182872A (en) * 1976-03-22 1980-01-08 American Home Products Corporation 4-(Lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acid chemical intermediates
US4032639A (en) * 1976-03-22 1977-06-28 American Home Products Corporation 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
NL8303657A (nl) 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE68908786T2 (de) 1988-06-16 1994-03-17 Smith Kline French Lab Condensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
FR2645152B1 (fr) 1989-03-30 1991-05-31 Lipha 3h-pteridinones-4, procedes de preparation et medicaments les contenant
US5043270A (en) 1989-03-31 1991-08-27 The Board Of Trustees Of The Leland Stanford Junior University Intronic overexpression vectors
CA2029651C (en) 1989-11-17 2000-06-06 David D. Davey Tricyclic pteridinones and a process for their preparation
US5198547A (en) 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
TW274550B (zh) * 1992-09-26 1996-04-21 Hoechst Ag
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US6096924A (en) * 1995-05-19 2000-08-01 Novartis Ag Process for the catalytic hydrogeneration of aromatic nitro compounds
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
KR100516088B1 (ko) 1996-09-23 2005-09-22 일라이 릴리 앤드 캄파니 올란자핀 이수화물 ｄ
CA2340180A1 (en) * 1998-08-11 2000-02-24 Pfizer Products Inc. 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones
EP1409487A1 (en) * 1999-09-15 2004-04-21 Warner-Lambert Company Llc Pteridinones as kinase inhibitors
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
IL151480A0 (en) 2000-03-06 2003-04-10 Warner Lambert Co 5-alkylpyrido[2,3-d] pyrimidines tyrosine kinase inhibitors
DE10018783A1 (de) 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
WO2002076985A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6806272B2 (en) * 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
WO2003020722A1 (de) * 2001-09-04 2003-03-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE526013T1 (de) * 2001-12-14 2011-10-15 Merck Serono Sa Verfahren zur herbeiführung einer ovulation über einen nicht-polypeptid-camp-spiegel-modulator
US20060079503A1 (en) 2002-05-03 2006-04-13 Schering Aktiengesellschaft Thiazolidinones and the use therof as polo-like kinase inhibitors
WO2004014899A1 (en) 2002-08-08 2004-02-19 Smithkline Beecham Corporation Thiophene compounds
US6862422B2 (en) * 2003-02-12 2005-03-01 Kabushiki Kaisha Toshiba Image forming apparatus and image forming method having pressing members for pressing a belt-like member
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
CN101200457A (zh) 2003-02-26 2008-06-18 贝林格尔英格海姆法玛两合公司 二氢蝶啶酮、其制法及作为药物制剂的用途
US20040180898A1 (en) * 2003-03-03 2004-09-16 Bang-Chi Chen Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazines
WO2004093906A1 (en) 2003-03-26 2004-11-04 Wyeth Immunogenic composition and methods
EP1617820B1 (en) 2003-04-14 2018-03-21 Vectura Limited Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
JP2007517828A (ja) * 2004-01-17 2007-07-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 気道の疾患を治療するための置換プテリジンの使用
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
DE102004034623A1 (de) * 2004-07-16 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2008510770A (ja) * 2004-08-26 2008-04-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｌｋ阻害剤としての新規プテリジノン
WO2006021548A1 (de) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
EP1915155A1 (en) 2005-08-03 2008-04-30 Boehringer Ingelheim International GmbH Dihydropteridinones in the treatment of respiratory diseases
US7439358B2 (en) * 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP1994002A1 (en) 2006-03-07 2008-11-26 AstraZeneca AB Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative

Also Published As

Publication number Publication date
AU2005311308B2 (en) 2012-04-12
CN101065381A (zh) 2007-10-31
EA200701164A1 (ru) 2007-12-28
HRP20120980T1 (hr) 2012-12-31
PL2436685T3 (pl) 2015-11-30
ES2548680T3 (es) 2015-10-20
PT1819706E (pt) 2012-12-06
PE20061061A1 (es) 2006-11-10
US7626019B2 (en) 2009-12-01
KR101395591B1 (ko) 2014-05-16
US20070213531A1 (en) 2007-09-13
SI1819706T1 (sl) 2013-01-31
CA2588857A1 (en) 2006-06-08
HUE027689T2 (hu) 2021-12-28
PE20090488A1 (es) 2009-05-27
HK1158199A1 (en) 2012-07-13
WO2006058876A1 (de) 2006-06-08
BRPI0518601A2 (pt) 2008-11-25
USRE43115E1 (en) 2012-01-17
ZA200703368B (en) 2008-09-25
SG141461A1 (en) 2008-04-28
AU2005311308A1 (en) 2006-06-08
RS52533B (en) 2013-04-30
JP5164574B2 (ja) 2013-03-21
EP1819706B1 (de) 2012-09-19
KR101362131B1 (ko) 2014-02-19
CN101065381B (zh) 2011-03-30
CN102070637A (zh) 2011-05-25
US20070219369A1 (en) 2007-09-20
DK1819706T3 (da) 2013-01-02
DE102004058337A1 (de) 2006-06-14
EP1819706A1 (de) 2007-08-22
ES2395829T3 (es) 2013-02-15
US20070213534A1 (en) 2007-09-13
US20060122393A1 (en) 2006-06-08
CN102093361A (zh) 2011-06-15
CY1113625T1 (el) 2016-06-22
KR20070092252A (ko) 2007-09-12
PL1819706T3 (pl) 2013-03-29
TW200628471A (en) 2006-08-16
NZ556182A (en) 2009-08-28
US20070213530A1 (en) 2007-09-13
EP2436685A1 (de) 2012-04-04
DK2436685T3 (en) 2015-09-14
IL183568A0 (en) 2007-09-20
MY147459A (en) 2012-12-14
KR20120136414A (ko) 2012-12-18
TWI362391B (en) 2012-04-21
HK1113489A1 (en) 2008-10-03
US20070208027A1 (en) 2007-09-06
MX2007006549A (es) 2007-06-18
US7238807B2 (en) 2007-07-03
US20070213529A1 (en) 2007-09-13
SG158848A1 (en) 2010-02-26
US20070213528A1 (en) 2007-09-13
IL183568A (en) 2015-02-26
CN102093361B (zh) 2014-05-07
CL2013002895A1 (es) 2014-03-14
CA2588857C (en) 2013-10-08
ME01470B (me) 2014-04-20
EA012624B1 (ru) 2009-10-30
EP2436685B1 (de) 2015-07-01
NO20072283L (no) 2007-06-28
CN102070637B (zh) 2012-09-26
JP2008521861A (ja) 2008-06-26
AR053100A1 (es) 2007-04-25
UY29233A1 (es) 2006-07-31
UA89390C2 (ru) 2010-01-25

Similar Documents

Publication Publication Date Title
HK1158200A1 (zh) 稠合的哌嗪- -酮衍生物的製備方法
IL180247A0 (en) Method for producing 4-
EP1813677A4 (en) PROCESS FOR MAKING BASIC SUBSTANCE
IL176767A0 (en) Production method
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
IL180125A0 (en) Methods for producing biodiesel
HK1107821A1 (en) Method for the production of dihydropteridinones
EP1767538A4 (en) PROCESS FOR PREPARING A 1-OXACEPHALOSPORIN-7ALPHA-METHOXY-3-CHLOROMETHYL DERIVATIVE
IL177233A0 (en) Method for producing polyisobutenylphenols
IL185627A0 (en) Alkyl-anilide producing method
PT1713756E (pt) Processo para a preparação de dinitrotolueno
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
ZA200704972B (en) Processes for producing 4-aminoquinazolines
EP1721871A4 (en) PROCESS FOR GENERATING BIOGAS
HK1118068A1 (en) Method for producing polycarbonates
EP1767563A4 (en) PROCESS FOR PREPARING POLYETHERES
EP1813596A4 (en) PROCESS FOR PREPARING ALPHA, ALPHA-DIFLUORAMINE
EP1780192A4 (en) PROCESS FOR PREPARING A DIBROMFLUORBENZOLE DERIVATIVE
EP1754738A4 (en) PROCESS FOR PREPARING POLYPYRIDINIUM
EP1743902A4 (en) METHOD OF PREPARING A 5-ALPHA PRIMING DERIVATIVE
PL1865784T3 (pl) Sposób wytwarzania pojedynczych porcji
EP1736540A4 (en) PROCESS FOR PRODUCING DIPEPTIDES
HK1106783A1 (en) Process for producing polyoxymethylene
EP1914313A4 (en) PROCESS FOR THE PRODUCTION OF CERCOSPORAMIDE
IL180189A (en) Process for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181126